Related Experiment Videos
[Pseudohypoparathyroidism]
G Bednarek-Tupikowska1, J Szymczak, A Szymańska
1Katedra i Klinika Endokrynologii i Diabetologii, Akademii Medycznej we Wrocławiu.
Przeglad Lekarski
|July 25, 2000
Summary
Pseudohypoparathyroidism (PHPT) is a rare genetic disorder causing resistance to parathyroid hormone (PTH), leading to low calcium and high phosphate. Early diagnosis and treatment are crucial to prevent severe complications like neurological defects.
Area of Science:
- Endocrinology
- Genetics
- Metabolic Disorders
Context:
- Pseudohypoparathyroidism (PHPT) is an uncommon endocrine disorder.
- Characterized by resistance of the kidneys and bones to parathyroid hormone (PTH).
- Leads to hypocalcemia, hyperphosphatemia, glandular hypertrophy, and PTH hypersecretion.
Purpose:
- To present data and discuss the characteristics of pseudohypoparathyroidism.
- To highlight the genetic etiology and clinical manifestations of PHPT.
- To emphasize the importance of early diagnosis and treatment.
Summary:
- PHPT presents with symptoms including tetany seizures, soft tissue calcifications, and congenital malformations.
- The disease has a genetic basis linked to the X chromosome, predominantly affecting women.
- Clinical variability depends on the specific genetic defect and tissue sensitivity.
- Three types of PHPT and pseudo-pseudo-HPT are recognized, typically appearing in infancy.
Impact:
- Early diagnosis and treatment with vitamin D3 or calcium are vital for patient outcomes.
- Delayed treatment can result in brain calcification, neurological deficits, and mental retardation.
- Prolonged PTH effects may cause bone destruction if receptors are fully sensitive.